chr9-19305477-C-A
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001330640.2(DENND4C):c.1437C>A(p.Asp479Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000942 in 1,613,604 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001330640.2 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DENND4C | ENST00000434457.7 | c.1437C>A | p.Asp479Glu | missense_variant | Exon 10 of 33 | 5 | NM_001330640.2 | ENSP00000473469.1 | ||
DENND4C | ENST00000494124.2 | n.753C>A | non_coding_transcript_exon_variant | Exon 6 of 28 | 1 | ENSP00000473273.1 | ||||
DENND4C | ENST00000602925.5 | c.1437C>A | p.Asp479Glu | missense_variant | Exon 10 of 32 | 5 | ENSP00000473565.1 | |||
DENND4C | ENST00000380437.8 | n.755C>A | non_coding_transcript_exon_variant | Exon 6 of 29 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152120Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000398 AC: 10AN: 251178 AF XY: 0.0000589 show subpopulations
GnomAD4 exome AF: 0.000101 AC: 148AN: 1461484Hom.: 0 Cov.: 30 AF XY: 0.0000949 AC XY: 69AN XY: 727054 show subpopulations
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152120Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74288 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.729C>A (p.D243E) alteration is located in exon 6 (coding exon 6) of the DENND4C gene. This alteration results from a C to A substitution at nucleotide position 729, causing the aspartic acid (D) at amino acid position 243 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at